comparemela.com
Home
Live Updates
Biogen, Bio-Thera Presents Positive Phase 3 Data For Tociliz
Biogen, Bio-Thera Presents Positive Phase 3 Data For Tociliz
Biogen, Bio-Thera Presents Positive Phase 3 Data For Tocilizumab Biosimilar In Rheumatoid Arthritis
WESTON (dpa-AFX) - At the Annual European Congress of Rheumatology on Friday, biotechnology companies Biogen Inc. (BIIB) and Bio-Thera Solutions, Ltd. presented positive Phase 3 data for BIIB800
Related Keywords
,
European Congress ,
Bio Thera Solutions Ltd ,
Biogen Inc ,
Annual European Congress ,
Bio Thera Solutions ,
Biogen ,
Hera ,
Presents ,
Positive ,
Hase ,
Data ,
Tocilizumab ,
Biosimilar ,
Rheumatoid ,
Arthritis ,